Zobrazeno 1 - 10
of 89
pro vyhledávání: '"I, Vrhovec"'
Publikováno v:
The International Journal of Biological Markers. 18:106-115
The present study on the prognostic and predictive value of serine proteases was conducted in 460 early breast cancer patients mostly treated with some kind of adjuvant systemic therapy: 156 received chemotherapy, 141 hormone therapy and 111 a combin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b3891f98d3ba3bdc12233353b1aaaec
https://doi.org/10.1177/172460080301800203
https://doi.org/10.1177/172460080301800203
Publikováno v:
The International Journal of Biological Markers. 17:33-41
The independent prognostic value of protease uPA and its inhibitor PAI-1 for survival in breast cancer patients is firmly established. However, there is very little data on the prognostic value of serine proteases and their inhibitors for locoregiona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::183d5fd0cedc9d851b5d4e99b80ec02d
https://doi.org/10.5301/jbm.2008.4665
https://doi.org/10.5301/jbm.2008.4665
Publikováno v:
Neoplasma. 52(1)
None of the established prognostic factors in breast cancer (BC) is able to determine the final outcome with certainity. Tumor biological factors involved in tumor invasion and metastasis, such as cathepsins and proteins of u-PA system, have been put
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9d872ea31b39c7b8002a44080193fa0d
https://pubmed.ncbi.nlm.nih.gov/15739019
https://pubmed.ncbi.nlm.nih.gov/15739019
Publikováno v:
The International journal of biological markers. 17(2)
The prognosis of cancer is primarily dependent on its potential to invade and metastasize. Data from both pre-clinical and clinical studies strongly suggest that serine proteases, as well as their inhibitors and receptor, play a central role in the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b202ce46e2d55e02aff0c0256891379
https://pubmed.ncbi.nlm.nih.gov/12113588
https://pubmed.ncbi.nlm.nih.gov/12113588
Autor:
M, Sprem, D, Babić, M, Abramić, I, Vrhovec, J, Skrk, D, Milicić, A, Ambriović Ristov, D, Kalafatić, M, Osmak
Publikováno v:
Croatian medical journal. 42(6)
To determine the activity of glutathione (GSH) and concentrations of glutathione S-transferases (GST), urokinase type plasminogen activator (uPA), and plasminogen activator inhibitor type 1 (PAI-1), and to evaluate their diagnostic and prognostic val
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f486bb911268b503e9dc9659528a643a
https://pubmed.ncbi.nlm.nih.gov/11740844
https://pubmed.ncbi.nlm.nih.gov/11740844
Publikováno v:
Neoplasma. 48(1)
Cysteine proteinases cathepsin (Cath) B and L and their endogenous inhibitors stefin (Stef) A and B concentrations were measured using a quantitative immunosorbent assay (ELISA; KRKA d.d., Novo mesto, Slovenia) in serum samples from 35 patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d263fa5a1a7c6caedf850dd6cf24adc1
https://pubmed.ncbi.nlm.nih.gov/11327540
https://pubmed.ncbi.nlm.nih.gov/11327540
Publikováno v:
Anticancer research. 20(5C)
The aim of the study was to evaluate the prognostic significance of tumour and serum concentrations of urokinase-type plasminogen activator (uPA), its type 1 inhibitor (PAI-1) and cathepsin D (Cath D) in patients with squamous cell carcinoma of the h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cb1b4f0d43cdd6d0d68a3b77ad41967b
https://pubmed.ncbi.nlm.nih.gov/11268487
https://pubmed.ncbi.nlm.nih.gov/11268487
Publikováno v:
Anticancer research. 19(4B)
The association between drug-resistance and three markers for invasive capacity: cathepsin D (Cath D), urokinase type plasminogen activator (uPA) and inhibitor of plasminogen activator type 1 (PAI-1) was examined in nine cervical and laryngeal carcin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8264ea980b05aff6cb5b16915bf28613
https://pubmed.ncbi.nlm.nih.gov/10652611
https://pubmed.ncbi.nlm.nih.gov/10652611
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 3(10)
The levels of cathepsins (Cats) B, H, and L and their inhibitors stefin A and cystatin C were determined in the sera of 43 patients with metastatic melanoma, in 54 patients with treated cutaneous melanoma with no evidence of metastatic disease, and i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b12df7b123bf8c1f8000a96131bc8d2e
https://pubmed.ncbi.nlm.nih.gov/9815568
https://pubmed.ncbi.nlm.nih.gov/9815568
Publikováno v:
Neoplasma. 44(3)
Doxorubicin shows a wide spectrum of activities in solid tumors, especially against breast carcinoma. The aim of this study was to examine if doxorubicin, when given at lower concentrations than applied in clinic, may induce changes in treated cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::491d74afaaad6356df561473f31e2ed8
https://pubmed.ncbi.nlm.nih.gov/9372856
https://pubmed.ncbi.nlm.nih.gov/9372856